Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 267.50
+4.50 (1.71%)
Feb 11, 2026, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 17.87 billion as of February 13, 2026. Its market cap has increased by 107.36% in one year.
Market Cap
17.87B
Enterprise Value
15.53B
Revenue
1.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
267.50
Market Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 17.87B, an increase of 596.65%. That is a compound annual growth rate of 43.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 17.87B | -12.01% |
| Dec 31, 2025 | 20.31B | 114.84% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 29.64B |
| TTY Biopharm Company | 20.74B |
| Grape King Bio | 18.07B |
| ScinoPharm Taiwan | 17.12B |
| Synmosa Biopharma | 16.25B |
| YungShin Global Holding | 14.70B |
| Foresee Pharmaceuticals | 13.47B |
| Handa Pharmaceuticals | 12.18B |